Takeda starts acquiring Russian OTC portfolio

29 January 2018 - Deborah Wilkes

Archived

Japan's Takeda is boosting its presence in Russia by acquiring a range of OTC products from US-based Unipharm in a deal worth JPY40.8 billion (USD0.37 billion).

Click tags below for more information on topics:

Takeda

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: